Abstract:ABSTRUCT Background Understanding the intercontinental and regional cancer burden attributable to modifiable risk factors is crucial for developing effective prevention strategies. Using GBD 2021 data, this study aims to identify disparities in cancer burden, predict future trends across different continents, and inform targeted interventions. Methods This study utilized the GBD 2021 framework to comprehensively assess the cancer burden across four world regions, with a focus on age-standardized incidence rates (ASIR), age-standardized mortality rates (ASMR), and disability-adjusted life years (DALYs). We systematically analyzed cancer-related risk factors using associations extracted from the GBD database. Through the application of average annual percent change (AAPC) and the Bayesian age-period-cohort (BAPC) model, we evaluated the cancer burden in each region from 2022 to 2035. Findings In 2021, cancer incidence and mortality rates varied widely across continents. The Americas led with an incidence of 1,633.49 per 100,000 and a mortality rate of 116.097, while Europe showed 950.248 and 132.578, respectively. Asia reported 636.893 incidence and 112.329 mortality, and Africa recorded the lowest rates at 332.175 and 98.594. High mortality is associated with elevated DALYs, notably in Europe with 3,284.53 DALYs per 100,000, reflecting the highest cancer burden. In high-income regions, lifestyle-related cancers-linked to smoking, colorectal, and breast cancers-prevail, while low-income areas, particularly sub-Saharan Africa, experience infection-driven cancers like cervical cancer . Younger females under 35 bear a higher cancer burden than males, but after 70, the trend reverses significantly, with men having higher mortality across all ages. Smoking is the leading mortality risk in the Americas, Europe, and Asia, while unsafe sex dominates in Africa, correlating with high cervical cancer incidence. From 1990 to 2021, high BMI and blood glucose have surged as cancer risk factors, driven by obesity and metabolic diseases. By 2035, projections indicate incidence will increase to 1,779.6 per 100,000 in the Americas, with stable mortality at 98.97, while Asia, Africa, and Europe are expected to see moderate incidence and mortality shifts, reflecting regional disparities in cancer prevention and management strategies. Interpretation This study reveals pronounced global disparities in cancer burden, shaped by economic development, healthcare access, and lifestyle factors. High-income regions, like North America and Europe, show high incidence but lower mortality rates due to robust screening and preventive measures. Conversely, low-income regions, especially sub-Saharan Africa, experience high mortality from preventable cancers, highlighting critical healthcare gaps. Gender analysis shows women have higher incidence due to screening, while men face higher mortality risks. Projected increases in incidence globally underscore the urgency for tailored cancer control strategies, focusing on prevention and healthcare access improvements across diverse socio-economic contexts.

Estimation of burden of cancer incidence and mortality in India: based on global burden of disease study 1990–2021

Burden of oral cancer and associated risk factors at national and state levels: A systematic analysis from the global burden of disease in India, 1990–2021

Cancer Burden and Attributable Risk Factors of Cancers in China: Epidemiological Insights and Comparisons With India

Global Trends in Incidence, Death, Burden and Risk Factors of Early-Onset Cancer from 1990 to 2019

Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme

Cervical cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with England and India based on the global burden of disease study 2019

Global burden of cancer and associated risk factors in 204 countries and territories, 1980–2021: a systematic analysis for the GBD 2021

Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018

Intercontinental and Regional Disparities in Cancer Burden: A Comprehensive Analysis of Trends and Projections Using 1990-2021 GBD Data with Forecasting to 2035

Article The Burden of Esophageal Cancer in China From 2013 to 2030 A Dynamic Cohort Modeling Study

Current and future burden of breast cancer: Global statistics for 2020 and 2040

The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019

Global Disparities of Cancer and Its Projected Burden in 2050

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions

An examination of colorectal cancer burden by socioeconomic status: evidence from GLOBOCAN 2018

Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study

Analysis and prediction of central nervous system tumor burden in China during 1990-2030

Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN

Cancer incidence among patients attending a tertiary care cancer hospital in central India – A retrospective study

Epidemiology and Socioeconomic Impact of Pancreatic Cancer: An Analysis of the Global Burden of Disease Study 1990–2019